Member Info for CR1909

And home trial results Parsley, was mention earlier that we could see a report from that ahead of any P3 results.

That could be the big one. If home results get the same exposure as P2 suddenly the mass media will be looking at a company with two sets of great results (assuming they are), P3 on the way and everything aligned for production.

CW- we h a similar discussion earlier.

Remember we thought vaccine news was priced in but we kept seeing a 5-10% hit every time a new announcent was made so I would be surprised if the first dosing RNS was already priced in.

Doc

For a while I think more than a few on here were really coming round to your concerns regarding the lack of PR.

However, I think the RNS has proven that SNG are focussing on the right things. Governments,health care providers and big pharma's all know who we are, what we have and the potential of this. Those are the people who will influence our long term success, drive the SP and save lives.

Raising awareness and expectation could easily cause the team to take an eye off the ball at such a pivotal time and make a mistake.

I'll be happy if we stay under the radar as long as we unleash hell when the next result (home trial and P3) are ready.

Yawn

Small steps - should be looking at 150p as the next milestone, then back to placing and then 200p.

I wonder how many of us will be logged in here at the back of 7 on Monday morning though to see if anything else lands?!

@BeforeGolf - I would love to see us get back over £2.

Would give a number of people on here a chance to get out as well if they want. Still have a few members stung by the placing and huge drop.

Those that want out - off you go. The rest of us can then strap ourselves in for the next few weeks, months and maybe even years.

Is it another RNS you've been thinking of?

Possibly Parsley, but we thought vaccine news had been factored into the SNG price but saw repeated 5-10% drops when further news was announced.

I wouldn't like to see us lose the positive momentum we have built last week.

With the new restrictions in place for much of the country which look like leading to another lockdown, the new strain of the virus and still Brexit uncertainty, I expect the markets to take a huge hit.

I could see SNG rising though, especially if we see a further RNS.

HideInPlainSight

Covid is here for years to come so COPD will be very much on the back burner. It would be a while before SNG are able to recruit patients or get time for reviews for any COPD trial.

The results of the phase 3 probably won't need to wow. The situation is desperate so the results need to just be slightly better than what is available already - which is a pretty low bar.

If one of the biggest sceptics on this board is quoting a 25% of success then I think that says it all.

No success that it works? What makes you think we will see different results in phase 3 (610 patients) to those in phase 2 (200 patients)?

We're pretty much just repeating phase 2 but on a slightly larger scale. Have you seen any better P2 results than those posted by Synairgen?

Afraid you'll probably just need to wait to find out.

The SP is this low just now because as it stands Synairgen are a small AIM company doing a trial. Once some orders come in and they are a profitable company with a successful P3, the SP will be huge compared to today.

Whatever the share price may eventually rise to, I will need to lie to my Mrs as she thinks we have about half of what we actually have invested!!

Either that or I could just keep the remainder for myself, tucked away.....

This must be a wind up?!

Matml, not something to base an investment decision on?

I am only here because of the French emergency use and our Indian licensing deal!! Never hear anything about it, instead the BoD insist on some trivial market in the USA......

Flockton - I suspect the reason for the posts about it were because we need something to discuss during long periods of silence.

It could have been something of significance, but we can see now it most likely wasn't.

Nothing wrong with speculation and discussion, bit it feels like the OP is simply using this to try and support a very negative viewpoint he holds.

Paolo

No I remember it too - was definitely mentioned on the board.

Synairgen have clearly been focussed on other things though, so do you have any insight into how much effort has gone into that? Are Doctors aware of SNG? Where would they even get their supplies from?

Maybe you could even help enlighten me - what was the scope of the approval? Is it similar to MAP use in the UK which we probably have more knowledge of and know to be very difficult and dependent on patient knowledge/persistence?

Hopefully nobody took offence - I think most of us got where you were coming from.

Am sure some people would have liked to have seen us finishing higher but that's human nature. There are some people here who get over enthusiastic with short term estimates. Remember a lot of casual investors would not be aware of the RNS, let alone the potential significance of it.

Look how much things have progressed in the last week or two - on all fronts. Getting closer to that rocket launching.

Not related to this particular thread but I can't wait to see what this board looks like if P3 goes the way we all hope/think.

Imagine an RNS dropping in Feb/March with some incredible news.

Me too - another £1k at 134.90

Hopefully see some returns on it immediately on Monday.

Org -save me a seat on that flight too.

With the vaccines and the radio silence from SNG over the past couple of months, I wondered if things would come good or whether this may turn into a hard luck story.

After the news today though I am confident that we are absolutely on the right track. It should just come down to the science now to prove the product works in the trials. That is where the Synairgen team should excel.

Onwards and upwards in 2021!